FBR Capital Upgrades Core Laboratories (CLB) to Outperform on 'Very Strong' Q4

Article Related Press Releases (1) Related Articles (1) Related SEC Filings (1) Stock Quotes (1) Comments (0)

FBR Capital upgraded Core Laboratories (NYSE: CLB) from Market Perform to Outperform with a price target of $150.00 (from $110.00) after "very strong" Q4.

The firm comments, "We are upgrading Core Laboratories (CLB) to Outperform from Market Perform on the heels of a very strong 4Q12 earnings report complemented by an equally impressive outlook. Given the attractive niche the company has carved out and the scarcity of attractive entry points, we believe investors looking for a pullback before getting more involved in the stock could miss the boat all together."

For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.

Shares of Core Laboratories closed at $117.20 yesterday, with a 52 week range of $94.72-$143.21.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
• Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy

Create E-mail Alert Related Categories

Analyst EPS View, Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?